Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-06 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.320 | -0.330 | -0.0100 | ||||
REV | 4.120M | 3.109M | -1.011M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
AXDX | Accelerate Diagnostics | 9.39 | -0.08 | -0.84% | 557.1M |
You can purchase shares of Accelerate Diagnostics (NASDAQ: AXDX) through any online brokerage.
Other companies in Accelerate Diagnostics’s space includes: Axogen (NASDAQ:AXGN), Vapotherm (NYSE:VAPO) and Oxford Immunotec Global (NASDAQ:OXFD).
The latest price target for Accelerate Diagnostics (NASDAQ: AXDX) was reported by BTIG on 2020-10-08. The analyst firm set a price target for 0.00 expecting AXDX to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Accelerate Diagnostics (NASDAQ: AXDX) is $9.39 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Accelerate Diagnostics.
There is no upcoming split for Accelerate Diagnostics.